Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Balance Sheet

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	334.7	147.3	204.8	92.3	159.3	73.7
Trading Asset Securities	21.3	21.3	20.5	19.5	19.5	19.7
Cash & Short-Term Investments	365	168.6	225.3	111.8	178.8	93.4
Cash Growth	65.23%	-25.17%	101.52%	-37.47%	91.44%	15.45%
Accounts Receivable	635.8	516.6	529	550.4	473.2	647.7
Other Receivables	-	368.6	31.9	34.8	110.9	-
Receivables	635.8	885.2	560.9	585.2	584.1	647.7
Inventory	475.6	413.7	661.7	672.8	653.9	294.3
Prepaid Expenses	-	14.1	14.8	16.2	9.5	-
Restricted Cash	26.1	76.2	36	-	-	-
Other Current Assets	27.5	474.2	82.6	76.7	73.3	103.2
Total Current Assets	1,530	2,032	1,581	1,463	1,500	1,139
Property, Plant & Equipment	313.2	314	709.1	752.3	749	901.3
Long-Term Investments	0.2	12.9	18.9	25.5	-	270.6
Other Intangible Assets	80.1	81.3	143.8	158.3	177.2	15
Long-Term Deferred Tax Assets	0.8	0.8	0.8	0.6	0.5	1.8
Total Assets	1,931	2,441	2,454	2,399	2,426	2,327
Accounts Payable	414.6	146.5	207.3	265.9	275.3	338.5
Accrued Expenses	-	108.2	105.9	114.9	154.6	-
Short-Term Debt	-	148.1	125.4	20.5	54.4	156.8
Current Portion of Long-Term Debt	21.9	152.5	90	37.5	-	234.1
Current Portion of Leases	15.1	49.4	38.6	39.2	31.9	-
Current Income Taxes Payable	15	5.2	7.7	5.9	5.9	-
Current Unearned Revenue	-	1.6	1.5	1.5	8.5	207
Other Current Liabilities	3.8	314.3	122.7	113.1	115.3	37
Total Current Liabilities	470.4	925.8	699.1	598.5	645.9	973.4
Long-Term Debt	363.7	612.5	765	712.5	665	220.9
Long-Term Leases	47.5	8.5	91.6	76	67.8	-
Long-Term Deferred Tax Liabilities	7.2	8.3	8	3.3	4	3.7
Total Liabilities	964.2	1,631	1,648	1,471	1,463	1,257
Common Stock	1,155	1,155	1,155	1,155	1,155	1,155
Retained Earnings	38.4	-119.5	-161.2	-65.8	-36.4	-107.7
Comprehensive Income & Other	-237.7	-236.7	-199.9	-173	-162.2	-146.5
Total Common Equity	956	799.1	794.2	916.5	956.7	901.1
Minority Interest	11.1	10.5	12	11.7	7.1	168.8
Shareholders' Equity	967.1	809.6	806.2	928.2	963.8	1,070
Total Liabilities & Equity	1,931	2,441	2,454	2,399	2,426	2,327
Total Debt	448.2	971	1,111	885.7	819.1	611.8
Net Cash (Debt)	-83.2	-802.4	-885.3	-773.9	-640.3	-518.4
Net Cash Per Share	-0.07	-0.69	-0.77	-0.67	-0.55	-0.49
Filing Date Shares Outstanding	1,133	1,155	1,155	1,155	1,155	1,155
Total Common Shares Outstanding	1,133	1,155	1,155	1,155	1,155	1,155
Working Capital	1,060	1,106	882.2	864.2	853.7	165.2
Book Value Per Share	0.84	0.69	0.69	0.79	0.83	0.78
Tangible Book Value	875.9	717.8	650.4	758.2	779.5	886.1
Tangible Book Value Per Share	0.77	0.62	0.56	0.66	0.67	0.77
Land	-	3.7	3.7	3.7	3.7	43.9
Buildings	-	368.2	508.1	508.1	505.6	623.9
Machinery	-	875.7	1,357	1,323	1,282	1,356
Construction In Progress	-	35.6	14.2	31.4	20.3	3.8
Leasehold Improvements	-	18.5	22.2	19.7	13.5	9.3

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.